Lauer and Hodes, from the National Institutes of Health (NIH), discuss the decades-long support of epidemiologic studies by NIH, the Agency for Health Research and Quality (AHRQ), the Veterans Administration, and other agencies.2 They expect this support to increase, given the renewed focus on comparative effectiveness research in recent legislation.